Résultats de la recherche - 16 results
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Anthony; Bacci, Sabrina; Kissling, Esther; Nunes, Baltazar; VEBIS‐EHR Working Group Source: Influenza Other Respir Viruses, Volume 18, Issue 4 (2024) Keywords: Aged Aged, 80 and over COVID-19 COVID-19 ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Irena; Lazar, Mihaela; Kubiliute, Ieva; Dürrwald, Ralf; Guiomar, Raquel; O'Donnell, Joan; Kristóf, Katalin; Nicolay, Nathalie; Bacci, Sabrina; Kissling, Esther; VEBIS SARI VE network team; Belgium ...
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Publication Type: Peer reviewed scientific article Authors: Fontán-Vela, Mario; Kissling, Esther; Nicolay, Nathalie; Toon Braeye; Izaak Van Evercooren; Holm Hansen, Christian; Emborg, Hanne-Dorthe; ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Marina; Wirtz, Gil; Tolksdorf, Kristin; Valenciano, Marta; Bacci, Sabrina; Kissling, Esther; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team Source: Eurosurveillance, Volume 28, Issue 47 ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
CJL; Lazar, Mihaela; Demlová, Regina; Wirtz, Gil; Amerali, Marina; Dürrwald, Ralf; Kunstár, Mihály Pál; Kissling, Esther; Bacci, Sabrina; Valenciano, Marta; I-MOVE-COVID-19 hospital study team; VEBIS ...
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
Esther Kissling; James Humphreys; Itziar Casado; Jesús Castilla; Iván Martínez-Baz; Hanne-Dorthe Emborg; Katrine Finderup Nielsen; Christian Holm Hansen; Hinta Meijerink; Anja Kristoffersen; Jostein ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Patricia CJL; Lazar, Mihaela; Demlová, Regina; Wirtz, Gil; Amerali, Marina; Dürrwald, Ralf; Kunstár, Mihály Pál; Kissling, Esther; Bacci, Sabrina; Valenciano, Marta; I-MOVE-COVID-19 hospital study team; ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Marina; Wirtz, Gil; Tolksdorf, Kristin; Valenciano, Marta; Bacci, Sabrina; Kissling, Esther; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital ...
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
Publication Type: Peer reviewed scientific article Authors: Kissling, Esther; Maurel, Marine; Emborg, Hanne-Dorthe; Whitaker, Heather; McMenamin, Jim; Howard, Jennifer; Trebbien, Ramona; Watson, ...
Comments on the “Evaluation of the Genotoxicity of Cell Phone Radiofrequency Radiation in Male and Female Rats and Mice Following Subchronic Exposure” by Smith‐Roe et al.
female rats and mice following subchronic exposure. Smith-Roe SL, Wyde ME, Stout MD, Winters JW, Hobbs CA, Shepard KG, Green AS, Kissling GE, Shockley KR, Tice RR, Bucher JR, Witt KL.Environ Mol Mutagen. ...